vs
Side-by-side financial comparison of ECARX Holdings Inc. (ECX) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
ECARX Holdings Inc. is the larger business by last-quarter revenue ($323.3M vs $185.2M, roughly 1.7× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -21.4%, a 22.3% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 6.5%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-86.5M).
ECARX Holdings Inc. is a global mobility technology provider specializing in integrated smart vehicle solutions, including in-vehicle infotainment systems, advanced driver assistance technologies, and connected car cloud services. It primarily partners with automotive manufacturers across the world, with a strong operational presence in the Chinese and European markets.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
ECX vs FOLD — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $323.3M | $185.2M |
| Net Profit | $-69.1M | $1.7M |
| Gross Margin | 15.5% | 85.7% |
| Operating Margin | -20.2% | 8.6% |
| Net Margin | -21.4% | 0.9% |
| Revenue YoY | 6.5% | 23.7% |
| Net Profit YoY | 12.8% | -88.5% |
| EPS (diluted) | $-0.20 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $185.2M | ||
| Q3 25 | — | $169.1M | ||
| Q2 25 | $323.3M | $154.7M | ||
| Q1 25 | — | $125.2M | ||
| Q4 24 | — | $149.7M | ||
| Q3 24 | — | $141.5M | ||
| Q2 24 | $303.5M | $126.7M | ||
| Q1 24 | — | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $17.3M | ||
| Q2 25 | $-69.1M | $-24.4M | ||
| Q1 25 | — | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | — | $-6.7M | ||
| Q2 24 | $-79.2M | $-15.7M | ||
| Q1 24 | — | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | 15.5% | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | 22.6% | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.3% | ||
| Q2 25 | -20.2% | -6.1% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | -22.2% | 11.8% | ||
| Q1 24 | — | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | -21.4% | -15.8% | ||
| Q1 25 | — | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | — | -4.8% | ||
| Q2 24 | -26.1% | -12.4% | ||
| Q1 24 | — | -43.9% |
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | $-0.20 | $-0.08 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | $-0.23 | $-0.05 | ||
| Q1 24 | — | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.2M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $-293.7M | $274.2M |
| Total Assets | $494.9M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | $86.2M | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | $108.4M | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | — | $274.2M | ||
| Q3 25 | — | $230.4M | ||
| Q2 25 | $-293.7M | $204.3M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | — | $194.0M | ||
| Q3 24 | — | $178.8M | ||
| Q2 24 | $-198.5M | $132.5M | ||
| Q1 24 | — | $130.7M |
| Q4 25 | — | $949.9M | ||
| Q3 25 | — | $868.8M | ||
| Q2 25 | $494.9M | $815.3M | ||
| Q1 25 | — | $789.8M | ||
| Q4 24 | — | $785.0M | ||
| Q3 24 | — | $786.6M | ||
| Q2 24 | $555.0M | $749.5M | ||
| Q1 24 | — | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-82.0M | $16.3M |
| Free Cash FlowOCF − Capex | $-86.5M | $16.0M |
| FCF MarginFCF / Revenue | -26.7% | 8.6% |
| Capex IntensityCapex / Revenue | 1.4% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.3M | ||
| Q3 25 | — | $35.7M | ||
| Q2 25 | $-82.0M | $-26.5M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | $-57.1M | $22.7M | ||
| Q1 24 | — | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | $-86.5M | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | $-64.9M | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | -26.7% | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | -21.4% | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | 1.4% | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | 2.6% | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECX
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
